Accounts Payable and Accrued Expenses

3 Months Ended

Mar. 31, 2024

Payables and Accruals [Abstract]

Accounts Payable and Accrued Expenses

11. ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses consisted of the following:

	March 31,		December 31,
(In thousands)	2024		2023
Accounts payable	$	77,052	$	65,649
Accrued compensation		47,208		83,107
Accrued other		81,594		91,805
Total accounts payable and accrued expenses	$	205,854	$	240,561

A summary of the Company’s current provision for sales discounts, allowances and reserves was as follows:

	March 31,		December 31,
(In thousands)	2024		2023
Medicaid rebates	$	196,773	$	213,845
Product discounts		14,685		15,121
Medicare Part D		15,665		20,569
Other		13,754		14,106
Total accrued sales discounts, allowances and reserves	$	240,877	$	263,641

Included in accounts payable was approximately $42.5 million and $34.5 million of amounts payable related to state U.S. Medicaid rebates as of March 31, 2024 and December 31, 2023, respectively.